Bristol-Myers Squibb (BMY) Misses Q4 EPS by 4c; Guides Below the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Bristol-Myers Squibb Co. (BMY) PT Lowered to $60 at Jefferies; Says Takeover 'Increasingly Likely'
January 27, 2017 8:26 AM ESTJefferies analyst Jeffrey Holford lowered estimates and his price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $60.00 (from $69.00) but said a takeover increasingly likely as the stock moves towards our ex-lung valuation of $44.
Holford commented, "Management seems to have scared investors... More
Bristol-Myers Squibb (BMY) Extends Losses Mid-Day
January 26, 2017 12:44 PM ESTBristol-Myers Squibb (NYSE: BMY) is seeing notable mid-day weakness following results this morning. The company's earnings call has already ended. Shares are down 4.4%.
... More